Goldman Sachs Group Inc Sutro Biopharma, Inc. Transaction History

Goldman Sachs Group Inc

$596 Billion
Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,712,115 shares of STRO stock, worth $1.42 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,712,115

Previous 1,712,115 -0.0%

Holding current value

$1.42 Million

Previous $1.11 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$0.65 - $2.12 $1,499 - $4,890	-2,307 Reduced 0.13%	1,712,115 $1.11 Million
Q4 2024 Feb 11, 2025	SELL	$1.82 - $4.4 $57,959 - $140,122	-31,846 Reduced 1.82%	1,714,422 $3.15 Million
Q3 2024 Nov 14, 2024	BUY	$2.88 - $5.01 $2.01 Million - $3.49 Million	696,896 Added 66.41%	1,746,268 $6.04 Million
Q2 2024 Aug 13, 2024	BUY	$2.92 - $5.33 $720,180 - $1.31 Million	246,637 Added 30.72%	1,049,372 $3.07 Million
Q1 2024 May 15, 2024	SELL	$3.27 - $5.65 $843,159 - $1.46 Million	-257,847 Reduced 24.31%	802,735 $4.54 Million
Q4 2023 Feb 13, 2024	SELL	$2.07 - $4.54 $63,774 - $139,872	-30,809 Reduced 2.82%	1,060,582 $4.55 Million
Q3 2023 May 14, 2024	BUY	$3.29 - $4.9 $101,361 - $150,964	30,809 Added 2.9%	1,091,391 $3.79 Million
Q3 2023 Nov 14, 2023	SELL	$3.29 - $4.9 $24,619 - $36,666	-7,483 Reduced 0.68%	1,091,391 $3.79 Million
Q2 2023 May 14, 2024	SELL	$4.25 - $5.88 $1.71 Million - $2.36 Million	-401,739 Reduced 26.77%	1,098,874 $5.11 Million
Q2 2023 Aug 14, 2023	SELL	$4.25 - $5.88 $1.71 Million - $2.36 Million	-401,739 Reduced 26.77%	1,098,874 $5.11 Million
Q1 2023 May 14, 2024	BUY	$4.48 - $8.45 $1.9 Million - $3.58 Million	423,145 Added 39.27%	1,500,613 $6.93 Million
Q1 2023 May 11, 2023	BUY	$4.48 - $8.45 $1.9 Million - $3.58 Million	423,145 Added 39.27%	1,500,613 $6.93 Million
Q4 2022 May 14, 2024	BUY	$5.41 - $8.08 $740,612 - $1.11 Million	136,897 Added 14.55%	1,077,468 $8.71 Million
Q4 2022 Feb 13, 2023	BUY	$5.41 - $8.08 $740,612 - $1.11 Million	136,897 Added 14.55%	1,077,468 $8.71 Million
Q3 2022 May 14, 2024	BUY	$5.17 - $7.11 $2.25 Million - $3.09 Million	434,511 Added 85.86%	940,571 $5.22 Million
Q3 2022 Nov 10, 2022	BUY	$5.17 - $7.11 $2.25 Million - $3.09 Million	434,511 Added 85.86%	940,571 $5.22 Million
Q2 2022 May 14, 2024	SELL	$3.41 - $8.95 $1.89 Million - $4.96 Million	-554,522 Reduced 52.28%	506,060 $2.64 Million
Q2 2022 Aug 15, 2022	BUY	$3.41 - $8.95 $353,545 - $927,927	103,679 Added 25.77%	506,060 $2.64 Million
Q1 2022 May 16, 2022	BUY	$7.78 - $15.31 $309,861 - $609,766	39,828 Added 10.99%	402,381 $3.31 Million
Q4 2021 Feb 14, 2022	BUY	$14.25 - $23.53 $518,643 - $856,397	36,396 Added 11.16%	362,553 $5.4 Million
Q3 2021 Nov 10, 2021	BUY	$16.88 - $22.38 $5.51 Million - $7.3 Million	326,157 New	326,157 $6.16 Million

Others Institutions Holding STRO

# of Institutions

119

Shares Held

60.6M

Call Options Held

95.8K

Put Options Held

38.5K

View Full List

About SUTRO BIOPHARMA, INC.

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $43.3M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

More about STRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Sutro Biopharma, Inc. Transaction History